IRVINE, Calif., July 15, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, ...

Please provide your email address to receive an email when new articles are posted on . Edwards Lifesciences announced that the FDA has approved an aortic valve conduit for use during bio-Bentall ...

Edwards Lifesciences Corp. has scored an approval from the U.S. FDA for the Konect Resilia aortic valved conduit, a ready-to-implant solution for bio-Bentall procedures.

(RTTNews) - Edwards Lifesciences Corp. (EW) has received approval from the U.S. FDA for the KONECT RESILIA aortic valved conduit, the first ready-to-implant solution for bio-Bentall procedures. The ...

The cord set eliminates conduit runs and wire pulling and eases line management. The Isys M12 version is a multifeatured design that includes 15407-2 HB/HA and 5599-2 H1/2/3 plug-in valves with ...

Cardiovascular surgeons who use bovine tissue valves for Bentall procedures no longer need to spend valuable operating room time manually assembling a valve with a conduit in the operating room.

MISSISSAUGA, ON, July 29, 2021 /CNW/ -- Edwards Lifesciences (Canada) Inc. has announced it received regulatory approval from Health Canada for both the KONECT RESILIA aortic valved conduit and the ...

TCT 1765: Ostial Left Main CTO Impella-Assisted Intervention in An 80-Year-Old Patient With Severe Left Ventricular Dysfunction Receive the the latest news, research, and presentations from major ...